{"id":"https://openalex.org/W2093279255","doi":"https://doi.org/10.1002/pds.2047","title":"Epidemiologic study of aripiprazole use and the incidence of suicide events","display_name":"Epidemiologic study of aripiprazole use and the incidence of suicide events","publication_year":2010,"publication_date":"2010-10-05","ids":{"openalex":"https://openalex.org/W2093279255","doi":"https://doi.org/10.1002/pds.2047","mag":"2093279255","pmid":"https://pubmed.ncbi.nlm.nih.gov/20925132"},"language":"en","primary_location":{"id":"doi:10.1002/pds.2047","doi":"https://doi.org/10.1002/pds.2047","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.2047","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073065681","display_name":"Marianne Ulcickas Yood","orcid":"https://orcid.org/0000-0003-4204-0871","observed_orcids":["https://orcid.org/0000-0003-4204-0871"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Marianne Ulcickas Yood","raw_affiliation_strings":["EpiSource, Newton, MA, USA. muyood@muyood.com","EpiSource, Newton, MA, USA","Yale University School of Medicine, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EpiSource, Newton, MA, USA. muyood@muyood.com","institution_ids":[]},{"raw_affiliation_string":"EpiSource, Newton, MA, USA","institution_ids":[]},{"raw_affiliation_string":"Yale University School of Medicine, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035786307","display_name":"Gerald N. DeLorenze","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerald DeLorenze","raw_affiliation_strings":["Kaiser Permanente, Oakland, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kaiser Permanente, Oakland, CA, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052785465","display_name":"Charles P. Quesenberry","orcid":"https://orcid.org/0000-0001-8272-9126","observed_orcids":["https://orcid.org/0000-0001-8272-9126"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles P. Quesenberry","raw_affiliation_strings":["Kaiser Permanente, Oakland, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kaiser Permanente, Oakland, CA, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112092593","display_name":"Ai\u2010Lin Tsai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ai\u2010Lin Tsai","raw_affiliation_strings":["Kaiser Permanente, Oakland, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kaiser Permanente, Oakland, CA, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032791172","display_name":"Syd Phillips","orcid":"https://orcid.org/0000-0001-9054-8587","observed_orcids":["https://orcid.org/0000-0001-9054-8587"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Syd Phillips","raw_affiliation_strings":["EpiSource, Newton, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EpiSource, Newton, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016335943","display_name":"Vincent J. Willey","orcid":"https://orcid.org/0000-0002-6473-6469","observed_orcids":["https://orcid.org/0000-0002-6473-6469"]},"institutions":[{"id":"https://openalex.org/I110357561","display_name":"University of the Sciences","ror":"https://ror.org/048gmay44","country_code":"US","type":"education","lineage":["https://openalex.org/I110357561"]},{"id":"https://openalex.org/I4405285906","display_name":"Carelon Research (United States)","ror":"https://ror.org/00n30fg43","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115830","https://openalex.org/I4405285906"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vincent J. Willey","raw_affiliation_strings":["University of the Sciences in Philadelphia, Philadelphia, PA (formerly with HealthCore, Wilmington, DE), USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of the Sciences in Philadelphia, Philadelphia, PA (formerly with HealthCore, Wilmington, DE), USA","institution_ids":["https://openalex.org/I110357561","https://openalex.org/I4405285906"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056515314","display_name":"Steve J. Niemcryk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steve J. Niemcryk","raw_affiliation_strings":["Bristol-Myers Squibb, Pennington, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pennington, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086196171","display_name":"Karen E. Wells","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Wells","raw_affiliation_strings":["Henry Ford Health System, Detroit, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Health System, Detroit, MI, USA","institution_ids":["https://openalex.org/I154057602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007668495","display_name":"Mary Lou Skovron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Lou Skovron","raw_affiliation_strings":["Bristol-Myers Squibb, Pennington, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pennington, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086835788","display_name":"Mark J. Cziraky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405285906","display_name":"Carelon Research (United States)","ror":"https://ror.org/00n30fg43","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115830","https://openalex.org/I4405285906"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark J. Cziraky","raw_affiliation_strings":["HealthCore, Wilmington, DE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HealthCore, Wilmington, DE, USA","institution_ids":["https://openalex.org/I4405285906"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036492697","display_name":"William H. Carson","orcid":"https://orcid.org/0000-0002-8876-9556","observed_orcids":["https://orcid.org/0000-0002-8876-9556"]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Carson","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109346434","display_name":"Susan A. Oliveria","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan A. Oliveria","raw_affiliation_strings":["EpiSource, Newton, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EpiSource, Newton, MA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5073065681"],"corresponding_institution_ids":["https://openalex.org/I32971472"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":2.3983,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.87766985,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"19","issue":"11","first_page":"1124","last_page":"1130"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.7397000193595886,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.7397000193595886,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10376","display_name":"Suicide and Self-Harm Studies","score":0.2476000040769577,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":1.0},{"id":"https://openalex.org/keywords/suicide-risk","display_name":"suicide risk","score":0.8230000138282776},{"id":"https://openalex.org/keywords/suicide-attempts","display_name":"suicide attempts","score":0.7680000066757202},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8679999709129333},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9700000286102295},{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":1.0},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.902999997138977},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":1.0},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":1.0},{"id":"https://openalex.org/keywords/ziprasidone","display_name":"ziprasidone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antipsychotic-safety","display_name":"antipsychotic safety","score":0.7689999938011169},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.7689999938011169},{"id":"https://openalex.org/keywords/hazard-ratio","display_name":"hazard ratio","score":0.5120000243186951}],"concepts":[{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.9371130466461182},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.792208194732666},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.7850300073623657},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.6081634759902954},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5989255905151367},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.5876857042312622},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.5506366491317749},{"id":"https://openalex.org/C2777270317","wikidata":"https://www.wikidata.org/wiki/Q205517","display_name":"Ziprasidone","level":4,"score":0.5434901118278503},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5394011735916138},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.46972644329071045},{"id":"https://openalex.org/C2780842732","wikidata":"https://www.wikidata.org/wiki/Q3518184","display_name":"Suicide attempt","level":4,"score":0.4572758972644806},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4262453317642212},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.41579416394233704},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.4016009569168091},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33115798234939575},{"id":"https://openalex.org/C3017944768","wikidata":"https://www.wikidata.org/wiki/Q1450463","display_name":"Poison control","level":2,"score":0.2937418818473816},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.24303629994392395},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.17407694458961487},{"id":"https://openalex.org/C526869908","wikidata":"https://www.wikidata.org/wiki/Q3298118","display_name":"Suicide prevention","level":3,"score":0.16945701837539673},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.1606907844543457},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.11053609848022461},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068180","descriptor_name":"Aripiprazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012306","descriptor_name":"Risk","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013405","descriptor_name":"Suicide","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D013406","descriptor_name":"Suicide, Attempted","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/pds.2047","doi":"https://doi.org/10.1002/pds.2047","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.2047","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},{"id":"pmid:20925132","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20925132","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and drug safety","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1984249564","https://openalex.org/W2007377313","https://openalex.org/W2063421821","https://openalex.org/W2097648013","https://openalex.org/W2109481947","https://openalex.org/W2113463828","https://openalex.org/W2159140454","https://openalex.org/W2164444243","https://openalex.org/W2164595809","https://openalex.org/W2166945572","https://openalex.org/W2243340394","https://openalex.org/W4233887075"],"related_works":["https://openalex.org/W2008696383","https://openalex.org/W2052752762","https://openalex.org/W4246740550","https://openalex.org/W1932851251","https://openalex.org/W2913352098","https://openalex.org/W4412941963","https://openalex.org/W1521774766","https://openalex.org/W1964155531","https://openalex.org/W4313627282","https://openalex.org/W2402877251"],"abstract_inverted_index":{"PURPOSE:":[0],"Because":[1],"second":[2],"generation":[3],"antipsychotics":[4],"(SGA)":[5],"might":[6],"affect":[7],"the":[8,21],"risk":[9,16,139,198],"of":[10,14,27,69,128,140,199,206,212],"suicide,":[11],"systematic":[12],"assessment":[13],"suicide":[15,42,70,75,107,141,175,200],"associated":[17,194],"with":[18,50,125,187,195,208],"SGA":[19,130,189],"in":[20,48,76,85,202],"postmarketing":[22,35],"setting":[23],"is":[24,192],"important":[25],"and":[26,72],"interest":[28],"to":[29,40],"regulatory":[30],"authorities.":[31],"To":[32],"fulfill":[33],"a":[34],"request,":[36],"our":[37],"objective":[38],"was":[39],"determine":[41],"event":[43,108],"(attempted":[44],"or":[45,52,214],"completed)":[46],"incidence":[47],"patients":[49,77,207],"schizophrenia":[51,213],"bipolar":[53,215],"disorder,":[54,174],"prescribed":[55],"aripiprazole.":[56],"METHODS:":[57],"Using":[58],"administrative":[59],"data":[60],"from":[61],"three":[62],"US":[63],"sources,":[64],"we":[65],"assessed":[66],"study":[67,158],"endpoints":[68],"attempts":[71],"death":[73],"by":[74],"aged":[78],"\u226518":[79],"enrolled":[80],"continuously":[81],"for":[82,157],"\u22653":[83],"months":[84],"their":[86,91],"health":[87],"plans":[88],"before":[89],"receiving":[90],"first":[92],"ever":[93],"antipsychotic":[94,102,165],"(November":[95],"2002-December":[96],"2005).":[97],"RESULTS:":[98],"Among":[99],"20":[100],"489":[101],"users":[103,127,133],"(8985":[104],"patient-years),":[105],"unadjusted":[106],"rates":[109],"(per":[110],"1000":[111],"patient-years)":[112],"were:":[113],"20.69":[114],"(aripiprazole);":[115],"23.99":[116],"(olanzapine);":[117],"32.33":[118],"(quetiapine);":[119],"19.69":[120],"(risperidone);":[121],"48.52":[122],"(ziprasidone).":[123],"Compared":[124],"current":[126],"other":[129,168,188],"combined,":[131,190],"aripiprazole":[132,191],"did":[134],"not":[135,193],"have":[136],"an":[137,196,203],"increased":[138,197],"events":[142,201],"(crude":[143],"hazard":[144],"ratio":[145],"(HR)":[146],"=":[147,153],"0.79,":[148],"95%CI:":[149,155],"0.48-1.30;":[150],"adjusted":[151],"HR":[152],"0.69,":[154],"0.42-1.14-(controlling":[156],"site,":[159],"age,":[160],"sex,":[161],"index":[162],"prescription":[163],"year,":[164],"use":[166],"history,":[167],"pharmacotherapy":[169],"exposure,":[170],"comorbidity":[171],"presence,":[172],"schizophrenia/bipolar":[173],"attempts,":[176],"number":[177],"inpatient/outpatient":[178],"encounters).":[179],"CONCLUSIONS:":[180],"In":[181],"this":[182],"large,":[183],"multi-site":[184],"study,":[185],"compared":[186],"inception":[204],"cohort":[205],"ICD-9/ICD-10":[209],"codes":[210],"indicative":[211],"disorder.":[216]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}